ArticleAccess microbiology2021
Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant.
Article in Access microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Disinfection methods against SARS-CoV-2: a systematic review.The Journal of hospital infection · 2022Pooled it
- Article
- Persistence of SARS-CoV-2 and its surrogate, bacteriophage Phi6, on surfaces and in water.Applied and environmental microbiology · 2023Article
- Porous Cellulose Thin Films as Sustainable and Effective Antimicrobial Surface Coatings.ACS applied materials & interfaces · 2023Article
- Evaluating the effects of air disinfectants in decontamination of COVID-19 aerosols.Health science reports · 2023Article
- A New Synergistic Strategy for Virus and Bacteria Eradication: Towards Universal Disinfectants.Pharmaceutics · 2022Article
- Disinfectants against SARS-CoV-2: A Review.Viruses · 2022Review
- CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.Journal of medical microbiology · 2022Article
- Rapid qualitative analysis in a mixed-methods evaluation of an infection prevention intervention in a UK hospital setting during the COVID-19 pandemic: A discussion of the CLEAN study methodology.Frontiers in sociology · 2022Article
- The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment.Environmental science and pollution research international · 2021Review
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
Until an effective vaccine against SARS-CoV-2 is available on a widespread scale, the control of the COVID-19 pandemic is reliant upon effective pandemic control measures. The ability of SARS-CoV-2 to remain viable on surfaces and in aerosols, means indirect contact transmission can occur and there is an opportunity to reduce transmission using effective disinfectants in public and communal spaces. Virusend (TX-10), a novel disinfectant, has been developed as a highly effective disinfectant against a range of microbial agents. Here we investigate the ability of Virusend to inactivate SARS-CoV-2. Using surface and solution inactivation assays, we show that Virusend is able to reduce SARS-CoV-2 viral titre by 4 log
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.